Top Picks: Accredited Activities

ASH 2018 Annual Meeting Highlights in AML

Naval Daver, MD; Mark J. Levis, MD, PhD; Daniel A. Pollyea, MD; Farhad Ravandi, MD; Eytan M. Stein, MD; and Eunice S. Wang, MD

Evolving Paradigms in AML: Symposium Replay

Farhad Ravandi, MD – Chair; Naval Daver, MD; Guillermo Garcia-Manero, MD; and Richard Stone, MD

  • PODCAST: What are the most important prognostic factors to consider in AML? - P. Desai, MD (2:19) - Posted 12/05
    podcast
  • VIDEO FAQ: How likely is it for patients with MDS to transform to AML? - J. Park, MD (3:33) - Posted 11/07
    video
  • VIDEO FAQ: What are the practical issues in FLT3 testing as it relates to PCR vs. NGS? - A. Perl, MD (3:18) - Posted 10/10
    video
  • VIDEO FAQ: What are the latest guidelines for molecular testing in AML? - J. Patel, MD (1:56) - Posted 07/24
    video
  • Additional activities...

Supporters

MediCom Worldwide, Inc. would like to recognize and thank the following companies for their educational support of Managing AML.com in 2018

  • Agios Pharmaceuticals, Inc.
  • Celgene Corporation
  • Daiichi Sankyo, Inc.
  • Helsinn Healthcare SA
  • Jazz Pharmaceuticals

MediCom Oncology Links

Please visit these other members of the MediCom Oncology family of sites.

Managing MDS Managing Myeloma The Practical Oncologist
Managing Lymphoma Partners in Pancreatic Cancer Emerging Solutions in Pain